BACKGROUND: The significance of detection of Trypanosoma cruzi DNA in blood of antibody-positive patients for risk of development of Chagas heart disease is not well established. The objective of this study was to compare detection of T. cruzi DNA with known clinical and laboratory markers of Chagas cardiomyopathy (CC) severity. METHODS: This is a case-control study nested within a retrospective cohort developed in Brazil to understand the natural history of Chagas disease. The study enrolled 499 T. cruzi seropositive blood donors (SP-BD) and 488 frequency matched seronegative control donors (SN-BD) who had donated between 1996 and 2002, and 101 patients with clinically diagnosed CC. In 2008-2010 all enrolled subjects underwent a health questionnaire, medical examination, electrocardiograms and echocardiograms and polymerase chain reaction (PCR) analyses. A blinded panel of three cardiologists adjudicated the outcome of CC. Trypanosoma cruzi kinetoplast minicircle sequences were amplified by real-time PCR using an assay with a sensitivity of one parasite per 20 mL of blood. All testing was performed on coded samples. RESULTS: Rates of PCR detection of T. cruzi DNA were significantly (P = 0.003) higher in CC patients and SP-BD diagnosed with CC (79/105 [75.2 %]) compared with SP-BD without CC (143/279 [51.3%]). The presence of parasitaemia was significantly associated with known markers of disease progression such as QRS and QT interval duration, lower left ventricular ejection fraction, higher left ventricular index mass, and elevated troponin and NTpro-BNP levels. CONCLUSION: Trypanosoma cruzi PCR positivity is associated with presence and severity of cardiomyopathy, suggesting a direct role of parasite persistence in disease pathogenesis.
BACKGROUND: The significance of detection of Trypanosoma cruzi DNA in blood of antibody-positive patients for risk of development of Chagas heart disease is not well established. The objective of this study was to compare detection of T. cruzi DNA with known clinical and laboratory markers of Chagas cardiomyopathy (CC) severity. METHODS: This is a case-control study nested within a retrospective cohort developed in Brazil to understand the natural history of Chagas disease. The study enrolled 499 T. cruzi seropositive blood donors (SP-BD) and 488 frequency matched seronegative control donors (SN-BD) who had donated between 1996 and 2002, and 101 patients with clinically diagnosed CC. In 2008-2010 all enrolled subjects underwent a health questionnaire, medical examination, electrocardiograms and echocardiograms and polymerase chain reaction (PCR) analyses. A blinded panel of three cardiologists adjudicated the outcome of CC. Trypanosoma cruzi kinetoplast minicircle sequences were amplified by real-time PCR using an assay with a sensitivity of one parasite per 20 mL of blood. All testing was performed on coded samples. RESULTS: Rates of PCR detection of T. cruzi DNA were significantly (P = 0.003) higher in CC patients and SP-BD diagnosed with CC (79/105 [75.2 %]) compared with SP-BD without CC (143/279 [51.3%]). The presence of parasitaemia was significantly associated with known markers of disease progression such as QRS and QT interval duration, lower left ventricular ejection fraction, higher left ventricular index mass, and elevated troponin and NTpro-BNP levels. CONCLUSION:Trypanosoma cruzi PCR positivity is associated with presence and severity of cardiomyopathy, suggesting a direct role of parasite persistence in disease pathogenesis.
Authors: Fabiana S Machado; Linda A Jelicks; Louis V Kirchhoff; Jamshid Shirani; Fnu Nagajyothi; Shankar Mukherjee; Randin Nelson; Christina M Coyle; David C Spray; Antonio C Campos de Carvalho; Fangxia Guan; Cibele M Prado; Michael P Lisanti; Louis M Weiss; Susan P Montgomery; Herbert B Tanowitz Journal: Cardiol Rev Date: 2012 Mar-Apr Impact factor: 2.644
Authors: Jose Antonio Marin-Neto; Anis Rassi; Carlos A Morillo; Alvaro Avezum; Stuart J Connolly; Sergio Sosa-Estani; Fernando Rosas; Salim Yusuf Journal: Am Heart J Date: 2008-07 Impact factor: 4.749
Authors: Angelica M Batista; Camila Aguiar; Eros A Almeida; Maria E Guariento; Jamiro S Wanderley; Sandra C B Costa Journal: Int J Infect Dis Date: 2010-09-15 Impact factor: 3.623
Authors: Alejandro G Schijman; Carlos A Vigliano; Rodolfo J Viotti; Juan M Burgos; Silvia Brandariz; Bruno E Lococo; Maria I Leze; Hector A Armenti; Mariano J Levin Journal: Am J Trop Med Hyg Date: 2004-02 Impact factor: 2.345
Authors: Ester C Sabino; Antonio L Ribeiro; Vera M C Salemi; Claudia Di Lorenzo Oliveira; Andre P Antunes; Marcia M Menezes; Barbara M Ianni; Luciano Nastari; Fabio Fernandes; Giuseppina M Patavino; Vandana Sachdev; Ligia Capuani; Cesar de Almeida-Neto; Danielle M Carrick; David Wright; Katherine Kavounis; Thelma T Goncalez; Anna Barbara Carneiro-Proietti; Brian Custer; Michael P Busch; Edward L Murphy Journal: Circulation Date: 2013-02-07 Impact factor: 29.690
Authors: Xutao Deng; Ester C Sabino; Edecio Cunha-Neto; Antonio L Ribeiro; Barbara Ianni; Charles Mady; Michael P Busch; Mark Seielstad Journal: PLoS One Date: 2013-11-20 Impact factor: 3.240
Authors: S M Keating; X Deng; F Fernandes; E Cunha-Neto; A L Ribeiro; B Adesina; A I Beyer; P Contestable; B Custer; M P Busch; E C Sabino Journal: Int J Cardiol Date: 2015-07-12 Impact factor: 4.164
Authors: Andre A L Carmo; Manoel O C Rocha; Jose L P Silva; Barbara M Ianni; Fabio Fernandes; Ester C Sabino; Antonio L P Ribeiro Journal: Int J Cardiol Date: 2015-04-11 Impact factor: 4.164
Authors: Herbert B Tanowitz; Fabiana S Machado; David C Spray; Joel M Friedman; Oren S Weiss; Jose N Lora; Jyothi Nagajyothi; Diego N Moraes; Nisha Jain Garg; Maria Carmo P Nunes; Antonio Luiz P Ribeiro Journal: Expert Rev Cardiovasc Ther Date: 2015-10-23
Authors: Meagan A Barry; Leroy Versteeg; Qian Wang; Jeroen Pollet; Bin Zhan; Fabian Gusovsky; Maria Elena Bottazzi; Peter J Hotez; Kathryn M Jones Journal: PLoS Negl Trop Dis Date: 2019-05-30
Authors: Julio V Cruz-Chan; Liliana E Villanueva-Lizama; Leroy Versteeg; Ashish Damania; Maria José Villar; Cristina González-López; Brian Keegan; Jeroen Pollet; Fabian Gusovsky; Peter J Hotez; Maria Elena Bottazzi; Kathryn M Jones Journal: Sci Rep Date: 2021-02-05 Impact factor: 4.379
Authors: Clareci Silva Cardoso; Antonio Luiz P Ribeiro; Claudia Di Lorenzo Oliveira; Lea Campos Oliveira; Ariela Mota Ferreira; Ana Luiza Bierrenbach; José Luiz Padilha Silva; Enrico Antonio Colosimo; João Eduardo Ferreira; Tzong-Hae Lee; Michael P Busch; Arthur Lawrence Reingold; Ester Cerdeira Sabino Journal: PLoS Negl Trop Dis Date: 2018-11-01
Authors: Lewis F Buss; Léa Campos de Oliveira-da Silva; Carlos H V Moreira; Erika R Manuli; Flavia C Sales; Ingra Morales; Clara Di Germanio; Cesar de Almeida-Neto; Sonia Bakkour; Paul Constable; Marcelo M Pinto-Filho; Antonio L Ribeiro; Michael Busch; Ester C Sabino Journal: PLoS Negl Trop Dis Date: 2020-10-27